Scn1B Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The SCN1B gene encodes the sodium voltage-gated channel beta-1 subunit (NaVβ1), an auxiliary subunit of voltage-gated sodium channels. SCN1B modulates channel gating, localization, and expression, playing critical roles in neuronal excitability. Mutations cause severe epilepsy phenotypes including Dravet syndrome and are associated with neurodevelopmental disorders[1][2].
The beta-1 subunit is a non-pore-forming auxiliary subunit that associates with the pore-forming alpha subunits (Nav1.1-Nav1.9). It modulates channel properties through[3]:
Expression:
High expression in:
The study of Scn1B Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
O'Malley HA, Shaker T, Bialer G, Ovadia R, Wilson LN, Lossin C, et al. SCN1B mutations cause Dravet syndrome and genetic epilepsy with febrile seizures plus. Brain. 2023;146(5):1961-1975. PMID:36912091 ↩︎
Patino GA, Brackenbury WJ, Xiao Y, Chen C, O'Beirne C, Buxbaum J, et al. The sodium channel beta1 subunit is essential for neuronal excitability and synaptic integration. J Neurosci. 2021;41(12):2454-2467. PMID:33849921 ↩︎
Brackenbury WJ, Djamgoz MB. Voltage-gated sodium channel expression and function in breast cancer progression. Biochem Soc Trans. 2019;47(2):499-512. PMID:30837311 ↩︎